Funding opportunities
2,862 live opportunities from Grants.gov, NIH, NSF, and more.
AI & Machine LearningAgriculture & Food ScienceBiomedical & HealthBiology & Life SciencesChemistry & MaterialsClimate & EnvironmentCybersecurity & ITDefense & SecurityEconomics & BusinessEducation & WorkforceEnergy & SustainabilityEngineeringHumanities & ArtsInfrastructure & TransportationMathematics & StatisticsPhysics & AstronomyPublic HealthSmall Business (SBIR/STTR)Social Sciences & PolicySpace & AerospaceVeterinary & Animal ScienceWater & Oceans
- Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.National Cancer InstitutePA-25-301 closes 5/31/2031up to $752,808activenih
- Advancing Renal Mass Diagnosis and Management through AI-Enhanced Decision Support Systems (RMM-DSS)National Cancer InstitutePA-25-301 closes 5/31/2031up to $632,670activenih
- Identifying individual clinical and environmental predictors of buprenorphine response to inform treatment for opioid use disorderNational Institute on Drug AbusePA-24-185 closes 5/31/2031up to $194,206activenih
- IL-15 mediated immune programming in nonhuman primates to improve vaccine efficacyNational Institute of Allergy and Infectious DiseasesPAR-23-073 closes 5/31/2031up to $189,000activenih
- Antibiotics-associated microbiota and functional changes in immune-mediated enterocolitis.National Institute of Allergy and Infectious DiseasesPA-24-182 closes 5/31/2031up to $184,030activenih
- Unraveling shared and unique mechanisms of autoimmunity using systems immunology approaches: Regulatory T cell dysfunction in LupusNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-182 closes 5/31/2031up to $165,240activenih
- Second-generation new-chemical-entity nanomedicine to target treatment resistance in pancreatic cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $667,482activenih
- Role of tumor biomechanics on drug-receptor engagementNational Cancer InstitutePA-25-301 closes 5/31/2031up to $648,579activenih
- Pathways for Regulatory Innovation and Strategic Modernization (PRISM)Food and Drug AdministrationRFA-FD-26-007 closes 5/31/2031up to $1,299,114activenih
- Optimization of a public neoantigen-based cancer prevention strategyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $659,570activenih
- The impact of the cord blood methylome on early-onset pediatric atopic dermatitisNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $784,314activenih
- Immune reprogramming with bioengineered scaffolds for the treatment of biofilm infectionNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $762,758activenih
- Modeling bone metastasis and tumor dormancy in prostate cancerNational Cancer InstitutePAR-25-130 closes 5/31/2031up to $820,855activenih
- Utilizing integrin-targeted PET imaging and therapeutics to predict and treat radiation-induced pulmonary fibrosisNational Cancer InstitutePAR-25-145 closes 5/31/2031up to $645,414activenih
- Immunotherapy for Glioblastoma by Targeting an Immunoregulatory NeuropeptideNational Cancer InstitutePA-25-301 closes 5/31/2031up to $567,754activenih
- Acetylation modulates T cell receptor signalingNational Cancer InstitutePA-25-301 closes 5/31/2031up to $498,582activenih
- Multimodal computational models for early prediction of peritoneal recurrence in gastric cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $513,915activenih
- Incretin Mimetics for Intercepting Obesity-Related Cancers: Effects and Underlying MechanismsNational Cancer InstitutePAR-23-279 closes 5/31/2031up to $656,285activenih
- Borrelia burgdorferi genotypic diversity, pathogenesis, and host cellular responsesNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $715,313activenih
- Lost in Translation: Inhibiting eIF4A to Treat AMLNational Cancer InstitutePA-25-301 closes 5/31/2031up to $409,463activenih
- Understanding and modulating paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury (TBI): A neuroimaging and physiologic data analytic approachNational Institute of Neurological Disorders and StrokePA-24-184 closes 5/31/2031up to $228,641activenih
- Causal Machine Learning and Trial Emulation for Precision Cardiovascular Risk Stratification in Obstructive Sleep Apnea (CLARITY-OSA)National Heart Lung and Blood InstitutePA-24-176 closes 5/31/2031up to $170,892activenih
- Lineage plasticity sensitizes FGFR3-mutant bladder cancer to FGFR inhibitorsNational Cancer InstitutePAR-25-129 closes 5/31/2031up to $637,473activenih
- Weak Cell Adhesion is a Prognostic Signature of Invasive CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $486,094activenih
- Digital Biomarkers and Remote Testing for Neurogenic Thoracic Outlet SyndromeEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-305 closes 5/31/2031up to $484,067activenih